Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
OtherMultiple Choice Questions Section
Open Access

Cognitive impairment

Taim Muayqil
Neurosciences Journal January 2016, 21 (1) 81-83;
Taim Muayqil
From the Division of Neurology, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail:
MBBS, FRCPC, Msc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

The Neurosciences Journal includes this section of multiple choice questions as part of its commitment to continuous education and learning in Neurosciences. Experts in various neuroscience specialties are invited to participate with their knowledge and expertise in this section.

Neurology, neurosurgery, and other board residents are encouraged to read this section to improve their knowledge and direct their reading for written examinations.

Choose the most appropriate single answer.

  1. A 65-year-old male presents with a 2-year history of forgetfulness. He needed to make more reminder notes and alerts on his smart phone to be on schedule. He is in charge of managing a small business, and noticed he cannot easily recall the names of new clients. Otherwise, the business is running well, and his decisions remain sound. His family and colleagues have noticed his struggles with recall but there have not been any changes in his performance. There was no significant past medical or surgical history. His mother had dementia in her senior years before she died from pneumonia. The neurological exam was normal including a full score on the Mini-Mental State Exam. On the Wechsler memory scale, he scored slightly lower than the controls and additional neuropsychological assessments revealed normal performance of the remaining cognitive domains. What is the most likely diagnosis?

    1. Mild Alzheimer’s dementia

    2. Mild cognitive impairment

    3. Pseudo-dementia secondary to depression and work related stress

    4. Cognitive changes associated with aging

  2. A 70-year-old woman with hypertension is referred by the family physician due to progressing memory complaints over the past 18 months. Her older sister died with Alzheimer’s disease 2 years earlier, and worries she will develop the same fate. After a thorough neurological evaluation, the diagnosis is amnestic-mild cognitive impairment. Her MRI was normal. What is her risk of converting to Alzheimer’s disease?

    1. 5-15% conversion rate over 5 years

    2. 20-40% annual conversion rate

    3. 5-15% annual conversion rate

    4. <1% with a normal MRI

  3. A 70-year-old retired engineer with a previous history of diabetes and a transient ischemic attack one year earlier is seeking a second opinion about his cognitive problem. He had recently seen a physician who diagnosed him with amnestic-mild cognitive impairment and advised him to stay involved in social and other cognitive activities in addition to tight blood sugar control and regular exercise. What does current evidence recommend about management at this stage?

    1. Starting a choline-esterase inhibitor

    2. Starting memantine

    3. Combining memantine with any choline-esterase inhibitor

    4. No pharmacological intervention is required

  4. A 59-year-old male physician has been suffering from a prominent rest tremor in the right upper extremity for the past 6 years; there is mild rigidity and bradykinesia more on the right than the left. Levodopa/Carbidopa treatment has controlled his symptoms reasonably well, and he remains in practice. His cognitive assessment 5 years earlier was normal. He has started to notice some difficulty with short-term memory and planning complex tasks. On cognitive assessment there is impairment on the Trail making test and mild planning difficulty on the clock drawing. His performance on memory tasks was average. Other cognitive domains were normal including verbal fluency, figure copying tasks, and neuropsychiatric assessment. What can you inform this patient about his risk of developing dementia?

    1. He currently has mild dementia, and it is expected to slowly worsen over the coming 3-5 years.

    2. Dementia with Parkinson’s disease has a cholinergic deficit and he should try a cholinesterase inhibitor.

    3. His current clinical profile suggests a lower likelihood of developing dementia over the next 3-5 years.

    4. Levodopa responsiveness can be seen in other degenerative disorders, and he should be reclassified as dementia with Lewy bodies.

  5. A retired 69-year-old university professor has been struggling with word finding difficulties for the past year. He cannot recall certain words mid-sentence and sometimes has to talk around the lost word in order to get his message across. Other than controlled diabetes and hypertension there is no relevant past or family history. His exam showed that there is a decrease in his naming ability, more prominent with low frequency words. His expressive language showed intact grammar, and rare phonological errors. His, repetition, reading and word comprehension were normal. His performance on short-term memory tests was borderline normal and there were no neurological deficits. What is the most likely underlying pathology associated with the clinical syndrome?

    1. Frontotemporal dementia-Tau.

    2. Frontotemporal dementia-TDP.

    3. Frontotemporal dementia-FUS.

    4. Alzheimer’s dementia-neurofibrillay tangles and amyloid plaques.

Answers:

  1. b

    The patient’s performance on neuropsychological testing revealed isolated deficit in the memory domain of cognition, resulting in an amnestic type of mild cognitive impairment (MCI). The patient does not meet criteria for dementia. Memory changes related to aging should be similar to age-matched controls. Depression and stress are usually associated with changes suggesting reduced effort and attention.1

  2. c

    This patient with a single domain type of MCI is at risk for progressing to dementia. While there is some variability in the literature, the annual conversion rate appears to be 5-15%.1,2

  3. d

    Various studies have shown mixed results of treating MCI with a choline esterase inhibitor. Pooled analyses have generally not suggested a benefit of memantine or cholinesterase inhibitors in MCI.3,4

  4. c

    Executive deficits without dementia are common in Parkinson’s disease patients. The additional presence of language disturbance, visuospatial impairment, an akinetic-rigid picture, older age and abnormal cognition at baseline would point to higher risks of developing dementia at 5 years. The long duration of motor symptoms before the appearance of cognitive symptoms does not support Lewy Body Dementia.5

  5. d

    This patient presents with a primary progressive aphasia known as the “logopenic variant”. More prominent grammatical errors and apraxia of speech would suggest non-fluent primary progressive aphasia, and impaired word comprehension is usually seen in the semantic variant. The logopenic variant has been found to be associated with Alzheimer’s type pathology in more than 70% of cases.6

  • Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

References

  1. ↵
    1. Petersen RC,
    2. Smith GE,
    3. Waring SC,
    4. Ivnik RJ,
    5. Tangalos EG,
    6. Kokmen E
    (1999) Mild cognitive impairment:clinical characterization and outcome. Arch Neurol 56, 303–308.
  2. ↵
    1. Mitchell AJ,
    2. Shiri-Feshki M
    (2009) Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119, 252–265.
  3. ↵
    1. Birks J,
    2. Flicker L
    (2006) Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 3, CD006104.
  4. ↵
    1. Buckley JS,
    2. Salpeter SR
    (2015) A Risk-Benefit Assessment of Dementia Medications:Systematic Review of the Evidence. Drugs Aging 32, 453–467.
  5. ↵
    1. Williams-Gray CH,
    2. Evans JR,
    3. Goris A,
    4. Foltynie T,
    5. Ban M,
    6. Robbins TW,
    7. et al.
    (2009) The distinct cognitive syndromes of Parkinson’s disease:5 year follow-up of the CamPaIGN cohort. Brain 132, 2958–2969.
  6. ↵
    1. Chare L,
    2. Hodges JR,
    3. Leyton CE,
    4. McGinley C,
    5. Tan RH,
    6. Kril JJ,
    7. et al.
    (2014) New criteria for frontotemporal dementia syndromes:clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry 85, 865–870.
PreviousNext
Back to top

In this issue

Neurosciences Journal: 21 (1)
Neurosciences Journal
Vol. 21, Issue 1
1 Jan 2016
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cognitive impairment
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Cognitive impairment
Taim Muayqil
Neurosciences Journal Jan 2016, 21 (1) 81-83;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cognitive impairment
Taim Muayqil
Neurosciences Journal Jan 2016, 21 (1) 81-83;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • References
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Childhood epilepsies
  • Discitis in children
  • Tethered cord syndrome
Show more Multiple Choice Questions Section

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire